Three endpoints of in vivo tumour radiobiology and their statistical estimation

International Journal of Radiation Biology

Volumn 86, Issue 2, 2010, Pages 164-173

  Demidenko, Eugene ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

Cell kill; Doubling time; Surviving fraction; Tumour growth delay

Indexed keywords

CANCER CELL; CANCER RESEARCH; CELL KILLING; COMPUTER PROGRAM; GEOMETRY; IN VIVO STUDY; NORMAL DISTRIBUTION; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RADIOBIOLOGY; REVIEW; SURVIVAL; TUMOR GROWTH; TUMOR VOLUME;

ANIMALS; CELL SURVIVAL; ENDPOINT DETERMINATION; MODELS, BIOLOGICAL; MODELS, STATISTICAL; NEOPLASMS, EXPERIMENTAL; PHOTOCHEMOTHERAPY; RADIOBIOLOGY;

ANIMALIA;

EID: 77249128458     PISSN: 09553002     EISSN: 13623095     Source Type: Journal    
DOI: 10.3109/09553000903419304     Document Type: Review

References (28)

1. Alley MC, Hollingshead MG, Dykes DJ, Waud WR. 2004. Human tumor xenograft models in NCI drug development. In: Teicher BA, Andrews PA, editors. Anticancer drug development guide. 2nd ed. Totowa, NJ: Human Press. pp 125-152.
2. Banks RB. 1994. Growth and diffusion phenomena. Berlin: Springer-Verlag.
3. Bassukas ID. 1993. A generalized tumor-growth delay assay for quantifying alterations of tumor regrowth patterns. Anticancer Research 13:1601-1606.
4. Bassukas ID, Hofmockel G. 2001. Nobody needs "relative tumour sizes" to compare tumour growth curves. Anticancer Research 21:1181-1182.
5. Begg AC. 1980. Analysis of growth delay data: Potential pitfalls. British Journal of Cancer 41:1639-1643.
6. Begg AC. 1987. Principles and practices of the tumor growth delay assay. In: Kallman RF, editor. Rodent tumor models in experimental cancer therapy. New York: McGraw-Hill. pp 114-121.
7. Bissery M-C, Guenard D, Gueritte-Voegeleina F, Lavelle F. 1991. Experimental antitumor activity of Taxotere (RP 56976, NSC 628503), a Taxol analogue. Cancer Research 51: 4845-4852.
8. Castorina P, Deisboeck TS, Gabriele P, Guiot C. 2007. Growth laws in cancer: Implication for radiotherapy. Radiation Research 168:349-356.
9. Demidenko E. 2004. Mixed models: Theory and applications. New York: Wiley.
10. Demidenko E. 2006. The assessment of tumour response to treatment. Applied Statistics 55:365-377.
11. Denekamp J. 1974. The response of a mouse sarcoma to single and divided doses of X-rays and fast neutrons. British Journal of Cancer 29:292-299.
12. Hall EJ. 2000. Radiobiology for the radiobiologist. 5th ed. Philadelphia: Lippincott.
13. Hanfelt JJ. 1997. Statistical approaches to experimental design and data analysis of in vivo studies. Breast Cancer Research and Treatment 46:279-302.
14. Heitjan DF, Manni A, Santen RJ. 1993. Statistical analysis of in vivo tumor growth experiments. Cancer Research 53: 6042-6050. 172 E.**
15. Demidenko Hou H, Khan N, Grinberg O, Yu H, Grinberg S, Lu S, Demidenko E, Steffen RP, Swartz HM. 2007. The effects of Efaproxyn (efaproxiral) on subcutaneous RIF-1 tumor oxygenation and enhancement of radiotherapy-mediated inhibition of tumor growth in mice. Radiation Research 168:218-225.
16. Jones DS, Sleeman DS. 2003. Differential equations and mathematical biology. London: Chapman & Hall/CRC.
17. Kallman RF. 1987. Rodent tumor models in experimental cancer therapy. New York: Pergamon Press.
18. Laird AK. 1983. Dynamics of tumour growth. British Journal of Cancer 18:490-502.
19. Norton L, Simon R, Brereton HD, Bogden AE. 1976. Predicting the course of Gompertzian growth. Nature 264:542-545.
20. Ozono S, Miyao N, Igarashi T, Marumo K, Nakazawa H, Fukuda M, Tsushima T, Tokuda N, Kawamura J, Murai M. 2004. Tumor doubling time of renal cell carcinoma measured by CT: Collaboration of Japanese Society of Renal Cancer. Japanese Journal of Clinical Oncology 34:82-85.
21. Papadopoulou MV, Ji M, Ji X, Bloomer WD, Hollingshead MG. 2002. Therapeutic advantage from combining paclitaxel with the hypoxia-selective cytotoxin NLCQ-1 in murine tumor-or human xenograft-bearing mice. Cancer Chemotherapy and Pharmacology 50:501-508.
22. Rygaard K, Spang-Thomsen M. 1997. Quantitation and Gompertzian analysis of tumor growth. Breast Cancer Research and Treatment 46:303-312.
23. Sakamoto K. 2004. Radiobiological basis for cancer therapy by total or half-body irradiation. Nonlinearity in Biology, Toxicology and Medicine 2:293-316.
24. Steel GG. 1977. Growth kinetics of tumours. Oxford: Clarendon Press.
25. Thomlinson RH, Graddock EA. 1967. The gross response of an experimental tumour to single doses of X-rays. British Journal of Cancer 21:108-123.
26. Tomimaru Y, Noura S, Ohue M, Okami J, Oda K, Higashiyama M, Yamada T, Miyashiro I, Ohigashi H, Yano M, Kodama K, Ishikawa O, Murata K, Yokouchi H, Sasaki Y, Kameyama M, Imaoka S. 2008. Metastatic tumor doubling time is an independent predictor of intrapulmonary recurrence after pulmonary resection of solitary pulmonary metastasis from colorectal cancer. Digestive Surgery 25: 220-225.
27. Yu RX, Holmgren RX. 2007. Endpoints for agents that slow tumor growth. Contemporary Clinical Trials 28:18-24.
28. Zhou XD, Pogue BW, Chen B, Demidenko E, Joshi R, Hoopes J, Hasan T. 2006. Pretreatment photosensitizer dosimetry reduces variation in tumor response. International Journal of Radiation Oncology Biology Physics 64:1211-1220.